共 37 条
HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo
被引:609
作者:
Zhang, Y
Li, N
Caron, C
Matthias, G
Hess, D
Khochbin, S
Matthias, P
机构:
[1] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland
[2] Fac Med, Inst Albert Bonniot, INSERM, U309, F-38706 La Tronche, France
关键词:
chromatin;
cytoskeleton;
deacetylase;
HDAC (histone deacetylase);
tubulin;
D O I:
10.1093/emboj/cdg115
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
Microtubules are cylindrical cytoskeletal structures found in almost all eukaryotic cell types which are involved in a great variety of cellular processes. Reversible acetylation on the epsilon-amino group of alpha-tubulin Lys40 marks stabilized microtubule structures and may contribute to regulating microtubule dynamics. Yet, the enzymes catalysing this acetylation/deacetylation have remained unidentified until recently. Here we report that beta-tubulin interacts with histone deacetylase-6 (HDAC-6) in a yeast two-hybrid assay and in vitro. We find that HDAC-6 is a micro tubule-associated protein capable of deacetylating alpha-tubulin in vivo and in vitro. HDAC-6's microtubule binding and deacetylation functions both depend on the hdac domains. Overexpression of HDAC-6 in mammalian cells leads to tubulin hypoacetylation. In contrast, inhibition of HDAC-6 function by two independent mechanisms-pharmacological (HDAC inhibitors) or genetic (targeted inactivation of HDAC-6 in embryonic stem cells)-leads to hyperacetylation of tubulin and microtubules. Taken together, our data provide evidence that HDAC-6 might act as a dual deacetylase for tubulin and histones, and suggest the possibility that acetylated non-histone proteins might represent novel targets for pharmacological therapy by HDAC inhibitors.
引用
收藏
页码:1168 / 1179
页数:12
相关论文